Location and duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes

American Journal of Respiratory and Critical Care Medicine

Volumn 182, Issue 9, 2010, Pages 1137-1143

  Collaco, J Michael ^a   Green, Deanna M ^a   Cutting, Garry R ^b   Naughton, Kathleen M ^b   Mogayzel Jr , Peter J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Antibiotic; Cystic fibrosis; Exacerbation; FEV1; Outcome

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HOME CARE; HOSPITAL CARE; HUMAN; LONG TERM CARE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; CHILD; CYSTIC FIBROSIS; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; INFUSIONS, INTRAVENOUS; LENGTH OF STAY; MALE; OUTPATIENT CLINICS, HOSPITAL; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 78349264246     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201001-0057OC     Document Type: Article

References (21)

1. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry Annual Data Report 2008 (accessed September 13, 2010). 2008. Available from: http:/www.cff.org
2. Balaguer A, de Gonzalez DJ. Home intravenous antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2008;CD001917.
3. Flume PA, Mogayzel PJ Jr, Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, Marshall BC. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med 2009;180:802-808.
4. Donati MA, Guenette G, Auerbach H. Prospective controlled study of home and hospital therapy of cystic fibrosis pulmonary disease. J Pediatr 1987;111:28-33.
5. Strandvik B, Hjelte L, Malmborg AS, Widen B. Home intravenous antibiotic treatment of patients with cystic fibrosis. Acta Paediatr 1992;81:340-344.
6. Bramwell EC, Halpin DM, Duncan-Skingle F, Hodson ME, Geddes DM. Home treatment of patients with cystic fibrosis using the 'Intermate': the first year's experience. J Adv Nurs 1995;22:1063-1067.
7. Wolter JM, Bowler SD, Nolan PJ, McCormack JG. Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects. Eur Respir J 1997;10:896-900.
8. Thornton J, Elliott RA, Tully MP, Dodd M, Webb AK. Clinical and economic choices in the treatment of respiratory infections in cystic fibrosis: comparing hospital and home care. J Cyst Fibros 2005;4:239-247. (Pubitemid 43013031)
9. Bosworth DG, Nielson DW. Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis. Pediatr Pulmonol 1997;24:42-47.
10. Esmond G, Butler M, McCormack AM. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis. J Clin Nurs 2006;15:52-60. (Pubitemid 43455092)
11. Pond MN, Newport M, Joanes D, Conway SP. Home versus hospital intravenous antibiotic therapy in the treatment of young adults with cystic fibrosis. Eur Respir J 1994;7:1640-1644. (Pubitemid 24294250)
12. Riethmueller J, Busch A, Damm V, Ziebach R, Stern M. Home and hospital antibiotic treatment prove similarly effective in cystic fibrosis. Infection 2002;30:387-391. (Pubitemid 35447470)
13. Proesmans M, Heyns L, Moons P, Havermans T, De BK. Real life evaluation of intravenous antibiotic treatment in a paediatric cystic fibrosis centre: outcome of home therapy is not inferior. Respir Med 2009;103:244-250.
14. Thornton J, Elliott R, Tully MP, Dodd M, Webb AK. Long term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis. Thorax 2004;59:242-246. (Pubitemid 38339882)
15. Nazer D, Abdulhamid I, Thomas R, Pendleton S. Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis. Pediatr Pulmonol 2006;41:744-749. (Pubitemid 44157357)
16. Bradley JM, Wallace ES, Elborn JS, Howard JL, McCoy MP. An audit of the effect of intravenous antibiotic treatment on spirometric measures of pulmonary function in cystic fibrosis. Ir J Med Sci 1999;168:25-28.
17. Termoz A, Touzet S, Bourdy S, Decullier E, Bouveret L, Colin C, Nove-Josserand R, Reix P, Cracowski C, Pin I, et al. Effectiveness of home treatment for patients with cystic fibrosis: the intravenous administration of antibiotics to treat respiratory infections. Pediatr Pulmonol 2008;43:908-915.
18. Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003;290:2588-2598. (Pubitemid 37443289)
19. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998;132:589-595.
20. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-734. (Pubitemid 13101554)
21. Redding GJ, Restuccia R, Cotton EK, Brooks JG. Serial changes in pulmonary functions in children hospitalized with cystic fibrosis. Am Rev Respir Dis 1982;126:31-36. (Pubitemid 12090851)